C2Biotechnologies

C2Biotechnologies

Menu
  • Main
  • About Us
      • History
      • Team
          • testimonials
      • FAQs
  • Product Services
  • Latest News
  • Contacts

Amylase Fusion Enzyme

  • Technology: Amylase Fusion Enzyme
  • Source: Recombinant Bacteria
  • Owner: C2 Biotechnologies
  • Commercial Arrangements: Joint Venture, Equity Investment, IP Acquisition
  • View Project

Description

The gene for the amylase fusion enzyme is cloned into a circular piece of DNA called an expression vector. Amylase fusion enzyme production is turned on by adding chemicals to the system. Enzyme expression is performed in bacterial cells and is directed outside into the culture medium. The fusion enzyme works over a much larger range of temperatures then current market products. This engineered feature faculties conversion of starchy feed stocks during mashing operations resulting in lower operating costs and higher glucose yields.

The Market

The amylase fusion enzyme technology has multiple applications in multiple market sectors: renewable energy, fermentation and corn syrup. The world enzyme industry is $4.1 billion and is estimated to increase by 7.6% annually through 2011. Grain processing encompasses all market sectors. Essentially 1 kg of amylase enzyme is used to convert 1 ton of grain into sugar. Current market prices for amylase enzyme are $2.12 - $4.77 / kg. In the USA 62,800,000 metric tons of corn was converted into glucose to be used as sweetener, fuel or fermentation products. Hence the total amylase enzyme market is estimated at $216 million. Based on our market study of bio-ethanol producers’ temperature control during mashing operations is important for enzyme addition and glucose yield. Concerns about enzyme costs, performance, customer support and ease of use were raised. As the USA moves toward foreign oil independence and relies more on renewable
energy demand for amylase enzymes will increase.

The Opportunity

C2 Biotechnologies (C2B), LLC seeks partners to license the production, marketing, sales and distribution of the amylase fusion enzyme technology while C2B retains manufacturing rights. Scientists at C2B have engineered a new amylase fusion enzyme that operates over a very broad range of temperatures. This property makes it easier to use especially during large mashing operations and results in increased yields while reducing operating costs. Up front licensing costs are based on licensee market.

 

  • Main
  • About Us
  • Product Services
  • Latest News
  • Contacts
C2Biotechnologies © 2023 Privacy policy
More Business Joomla Themes at TemplateMonster.com